Home Tags Fate Therapeutics (NASDAQ:FATE) reports 1Q17 Loss Confined

Tag: Fate Therapeutics (NASDAQ:FATE) reports 1Q17 Loss Confined

Fate Therapeutics (NASDAQ:FATE) reports 1Q17 Loss Confined

Fate Therapeutics (NASDAQ:FATE) headquartered in San Diego, California, announced net loss for the first quarter of $ 10.13 million or $ 0.24 per share,...

Latest News

STAY CONNECTED

274FansLike
29FollowersFollow